翔宇药业 (832276.OC)

+ 收藏

财务摘要(报告期)(翔宇药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.160.240.130.130.11
 每股收益 - 稀释(元) 0.16-0.13-0.11
 每股收益 - 期末股本摊薄(元) 0.160.240.130.130.11
 每股净资产BPS(元) 3.743.593.483.353.33
 每股经营活动产生的现金流量净额(元) 0.23-0.45-0.100.480.22
 每股营业收入(元) 1.443.001.532.911.37
关键比率:
 净资产收益率 - 摊薄(%) 4.156.693.763.773.22
 净资产收益率 - 加权(%) 4.236.923.843.843.22
 净资产收益率 - 平均(%) 4.246.923.833.843.28
 净资产收益率 - 扣除(%) 4.056.383.763.553.20
 总资产净利率 - 平均(%) 2.814.632.552.502.18
 总资产报酬率ROA(%) 4.066.483.523.833.25
 投入资本回报率ROIC(%) 3.986.523.784.463.27
 销售毛利率(%) 46.8841.5443.3539.8941.64
 销售净利率(%) 10.787.968.534.327.81
 资产负债率(%) 36.7229.8630.7935.3932.98
 资产周转率(倍) 0.260.580.300.580.28
 销售商品提供劳务收到的现金/营业收入(%) 98.6889.6398.3289.0081.66
 营业利润同比增长率(%) 25.80124.5618.1479.4535.09
 营业收入同比增长率(%) -5.803.1311.2821.864.54
 利润总额同比增长率(%) 22.99124.0117.6981.8835.11
 归属母公司股东的净利润同比增长率(%) 18.7290.1822.0857.1335.43
 扣非后归属母公司股东的净利润同比增长率(%) 15.9992.6822.86103.9742.88
 总资产同比增长率(%) 17.49-1.321.296.50-1.61
 总负债同比增长率(%) 40.12-16.74-5.4511.62-10.33
 净资产同比增长率(%) 7.477.174.643.923.37
利润表摘要:
 营业总收入(元) 276,005,476.42575,028,739.64293,008,292.05557,583,607.56263,298,083.46
 营业总成本(元) 239,794,379.62508,819,078.82260,825,504.52500,961,861.22237,095,900.63
 营业收入(元) 276,005,476.42575,028,739.64293,008,292.05557,583,607.56263,298,083.46
 营业利润(元) 35,807,180.2854,049,898.2028,462,871.0324,069,666.6324,091,710.35
 利润总额(元) 34,998,063.5454,004,257.9828,456,467.3724,107,500.6724,178,531.24
 净利润(元) 29,764,829.6345,764,937.0825,000,616.9924,063,128.6820,551,751.55
 归属母公司股东的净利润(元) 29,808,069.2846,017,019.1825,107,803.8724,197,087.3920,566,746.69
 非经常性损益(元) 724,954.012,126,960.9134,506.891,423,510.41158,797.76
 归属母公司股东的净利润扣除非经常性损益(元) 29,083,115.2743,890,058.2725,073,296.9822,773,576.9820,407,948.93
资产负债表摘要:
 流动资产(元) 617,977,696.47450,130,291.21413,165,977.98422,556,267.96403,938,126.45
 固定资产(元) 293,673,950.52308,760,501.56324,125,647.01330,389,132.30336,395,200.58
 资产总计(元) 1,134,642,183.02981,346,757.61965,722,500.75994,480,271.09953,466,962.57
 流动负债(元) 407,284,257.41283,753,661.63289,274,267.55343,086,248.32305,607,023.88
 非流动负债(元) 9,302,919.839,302,919.838,042,332.668,882,332.668,859,625.71
 负债合计(元) 416,587,177.24293,056,581.46297,316,600.21351,968,580.98314,466,649.59
 股东权益(元) 718,055,005.78688,290,176.15668,405,900.54642,511,690.11639,000,312.98
 归属母公司股东的权益(元) 717,594,056.17687,785,986.89667,703,222.62641,755,418.75638,125,078.05
 资本公积(元) 193,294,752.02193,294,752.02194,134,752.02193,294,752.02193,294,752.02
 盈余公积(元) 15,776,222.0515,776,222.0515,776,222.0515,776,222.0515,776,222.05
 未分配利润(元) 316,797,082.10286,989,012.82266,066,248.55240,958,444.68237,328,103.98
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 272,375,652.79515,422,468.96288,072,366.52496,277,043.93215,018,480.81
 经营活动产生的现金净流量(元) 43,441,264.42-86,467,492.18-18,539,531.4291,460,316.9442,469,403.84
 购建固定无形长期资产支付的现金(元) 12,018,946.991,154,861.987,545,937.456,430,920.293,828,952.48
 投资支付的现金(元) 100.00--9,988,000.009,988,000.00
 投资活动产生的现金净流量(元) -11,898,946.97-1,119,714.74-7,524,470.21-5,946,413.70-3,261,894.00
 取得借款收到的现金(元) 203,500,000.00207,800,000.00112,900,000.00192,800,000.00102,900,000.00
 筹资活动产生的现金净流量(元) 132,512,275.3946,036,738.66-22,434,988.16-38,857,680.04-21,683,212.49
 现金及现金等价物净增加(元) 164,054,592.84-41,550,468.26-48,498,989.7946,656,223.2017,524,297.35
 期末现金及现金等价物余额(元) 215,515,073.0415,460,480.208,511,958.6757,010,948.4627,879,022.25
 折旧与摊销(元) 23,733,003.7348,489,596.1124,459,298.6049,922,360.2324,233,241.94
公告日期 2024-08-272024-04-192023-08-252023-04-262022-08-19
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院